Enabling individualized therapy through nanotechnology
…, E Blanco, RE Serda, A Grattoni, A Ziemys… - Pharmacological …, 2010 - Elsevier
Individualized medicine is the healthcare strategy that rebukes the idiomatic dogma of ‘losing
sight of the forest for the trees’. We are entering a new era of healthcare where it is no …
sight of the forest for the trees’. We are entering a new era of healthcare where it is no …
[HTML][HTML] Transport barriers and oncophysics in cancer treatment
S Nizzero, A Ziemys, M Ferrari - Trends in cancer, 2018 - cell.com
Transport processes in cancer are the focus of transport oncophysics (TOP). In the TOP
approach, the sequential negotiation of transport barriers is critical to both drug delivery and …
approach, the sequential negotiation of transport barriers is critical to both drug delivery and …
[HTML][HTML] Cooperative, nanoparticle-enabled thermal therapy of breast cancer
Despite decades of effort on research and drug development for cancer treatment, cancer still
remains one of the major causes of human deaths in the world [1]. Human cancers consist …
remains one of the major causes of human deaths in the world [1]. Human cancers consist …
[HTML][HTML] VEGFR2 activity on myeloid cells mediates immune suppression in the tumor microenvironment
Angiogenesis, a hallmark of cancer, is induced by vascular endothelial growth factor–A (hereafter
VEGF). As a result, anti-VEGF therapy is commonly used for cancer treatment. Recent …
VEGF). As a result, anti-VEGF therapy is commonly used for cancer treatment. Recent …
Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics
Nanovectors hold substantial promise in abating the off-target effects of therapeutics by
providing a means to selectively accumulate payloads at the target lesion, resulting in an …
providing a means to selectively accumulate payloads at the target lesion, resulting in an …
Physicochemical properties affect the synthesis, controlled delivery, degradation and pharmacokinetics of inorganic nanoporous materials
IK Yazdi, A Ziemys, M Evangelopoulos… - …, 2015 - Future Medicine
Controlling size, shape and uniformity of porous constructs remains a major focus of the
development of porous materials. Over the past two decades, we have seen significant …
development of porous materials. Over the past two decades, we have seen significant …
Improved multiplex immunohistochemistry for immune microenvironment evaluation of mouse formalin-fixed, paraffin-embedded tissues
Immune profiling of tissue through multiplex immunohistochemistry is important for the
investigation of immune cell dynamics, and it can contribute to disease prognosis and evaluation …
investigation of immune cell dynamics, and it can contribute to disease prognosis and evaluation …
Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment
The capillary wall is the chief barrier to tissue entry of therapeutic nanoparticles, thereby
dictating their efficacy. Collagen fibers are an important component of capillary walls, affecting …
dictating their efficacy. Collagen fibers are an important component of capillary walls, affecting …
Hierarchical modeling of diffusive transport through nanochannels by coupling molecular dynamics with finite element method
A Ziemys, M Kojic, M Milosevic, N Kojic… - Journal of …, 2011 - Elsevier
We present a successful hierarchical modeling approach which accounts for interface
effects on diffusivity, ignored in classical continuum theories. A molecular dynamics derived …
effects on diffusivity, ignored in classical continuum theories. A molecular dynamics derived …
A robust nanofluidic membrane with tunable zero-order release for implantable dose specific drug delivery
D Fine, A Grattoni, S Hosali, A Ziemys, E De Rosa… - Lab on a Chip, 2010 - pubs.rsc.org
This manuscript demonstrates a mechanically robust implantable nanofluidic membrane
capable of tunable long-term zero-order release of therapeutic agents in ranges relevant for …
capable of tunable long-term zero-order release of therapeutic agents in ranges relevant for …